Description

(-)-α-(4-Chlorophenyl)Benzylamine (+)-Tartrate Salt is a high-purity chiral intermediate and resolving agent, essential for the synthesis of enantiomerically pure pharmaceutical compounds. Its value lies in providing a critical, optically active building block that enables the production of single-isomer active pharmaceutical ingredients (APIs) with enhanced efficacy and safety profiles. This compound is primarily needed by research institutions and manufacturers in the pharmaceutical, agrochemical, and fine chemical industries for developing new chiral drugs, catalysts, and advanced materials.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of novel therapeutic agents, particularly in central nervous system (CNS) and cardiovascular drug candidates.
• Chiral Resolving Agent: Used for the optical resolution of racemic mixtures to isolate desired enantiomers in fine chemical synthesis.
• Asymmetric Catalysis: Serves as a precursor or ligand in catalytic systems for stereoselective chemical transformations.
• Agrochemical Research: Employed in the synthesis of enantiopure pesticides and herbicides where specific stereochemistry impacts biological activity.
• Academic & Industrial R&D: A valuable tool for methodological studies in organic chemistry and process development for scale-up.
• Reference Standard: Used as an analytical standard for quality control and method validation in regulatory filings.

Basic Information

Product Name	(-)-α-(4-Chlorophenyl)Benzylamine (+)-Tartrate Salt
CAS No.	1159295-40-5
Molecular Formula	C17H18ClNO6
Molecular Weight	367.78 g/mol
Synonyms	(-)-α-(4-Chlorophenyl)benzylamine (+)-tartrate; (R)-(-)-α-(4-Chlorophenyl)benzylamine L-(+)-tartrate salt; (1R)-1-(4-Chlorophenyl)-1-phenylethanaminium (2R,3R)-2,3-dihydroxybutanedioate; 4-Chloro-α-methylbenzenemethanamine (R)-(-) tartrate salt; (R)-1-(4-Chlorophenyl)-1-phenylethylamine hydrogen tartrate; CPBAT; Chiral amine tartrate salt.
EINECS	Contact for details

Quality Control

Our (-)-α-(4-Chlorophenyl)Benzylamine (+)-Tartrate Salt is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including chiral purity assessment by HPLC, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) with detailed chromatographic data are provided and can be tailored to support regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥98.0%
Chiral Purity (HPLC)	≥99.0% ee
Loss on Drying	≤1.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.